You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 148 No. 7, July 1988 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (44)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Varicella-Zoster Infection in Adult Cancer Patients

A Population Study

James J. Rusthoven, MD, FRCP(C); Paul Ahlgren, MD, FRCP(C); Tahany Elhakim, MS; Patricia Pinfold, RN; Joan Reid; Lesley Stewart, RN; Ronald Feld, MD, FRCP(C)

Arch Intern Med. 1988;148(7):1561-1566.


Abstract

• In a retrospective review of varicella-zoster (V-Z) infections In adult cancer patients, 766 episodes of V-Z infection were studied among 740 patients seen at a large comprehensive cancer center from 1972 to 1980. The highest risk of infection was present among patients with lymphoma and leukemia. The risk of dissemination of V-Z Infection was significantly associated with the presence of active tumor at the time of infection. The site of the primary tumor correlated with the site of subsequent zoster infection among patients with breast cancer, cancer of the respiratory tract, and gynecologic cancer. Pain attributable to V-Z Infection was present in a large majority of episodes. The median time from the completion of therapy to the onset of infection was seven months for patients receiving radiotherapy and less than one month for those receiving chemotherapy. Various attributes of this study group were compared with those of previously studied cancer and noncancer populations.

(Arch Intern Med 1988;148:1561-1566)



Author Affiliations

From the Toronto-Bayview Regional Cancer Center (Dr Rusthoven), and the Princess Margaret Hospital, Toronto (Drs Ahlgren and Feld, and Mss Elhakim, Pinfold, Reid, and Stewart). Dr Rusthoven is now with Hamilton Regional Cancer Center, Hamilton, Ontario.


Footnotes

Accepted for publication Feb 10, 1988.

Reprint requests to Hamilton Regional Cancer Center, 711 Concession St, Hamilton, Ontario, Canada L8V 1C3 (Dr Rusthoven).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Development of Varicella-Zoster Virus Infection in Patients with Chronic Myelogenous Leukemia Treated with Imatinib Mesylate
Mattiuzzi et al.
Clin. Cancer Res. 2003;9:976-980.
ABSTRACT | FULL TEXT  

Postherpetic Neuralgia: Predicting and Preventing Risk
Kost and Straus
Arch Intern Med 1997;157:1166-1167.
ABSTRACT  

Risk Factors for Postherpetic Neuralgia
Choo et al.
Arch Intern Med 1997;157:1217-1224.
ABSTRACT  

Postherpetic Neuralgia -- Pathogenesis, Treatment, and Prevention
Kost and Straus
NEJM 1996;335:32-42.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1988 American Medical Association. All Rights Reserved.